PAHC
PAHC
US71742Q1067
Phibro Animal Health Corporatio
Loading chart...

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Latest News

Related stocks

ANIP
ANIP • United States
ANI Pharmaceuticals, Inc.
73.89 USD
1.7B USD 1Y -21.5%
PCRX
PCRX • United States
Pacira BioSciences, Inc.
36.31 USD
1.45B USD 1Y +55.4%
PBH
PBH • United States
Prestige Consumer Healthcare In
48.23 USD
2.28B USD 1Y -24.4%
BCRX
BCRX • United States
BioCryst Pharmaceuticals, Inc.
8.55 USD
2.18B USD 1Y +13.9%
SUPN
SUPN • United States
Supernus Pharmaceuticals, Inc.
42.67 USD
2.48B USD 1Y -12.2%
HROW
HROW • United States
Harrow, Inc.
29.36 USD
1.1B USD 1Y -23.2%
LQDA
LQDA • United States
Liquidia Corporation
27.38 USD
2.45B USD 1Y +16.4%
ETON
ETON • United States
Eton Pharmaceuticals, Inc.
55.21 USD
1.58B USD 1Y +161.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
47.2% p.a.
Max Drawdown (5Y)
-57.9%
Sharpe Ratio (5Y)
0.18
Beta Factor
0.42
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 206%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (53.5%) is noticeably higher than the 5Y average (47.2%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (47.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.1% in the extended horizon.
ende